| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |